Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics

References

• Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke. 2005;36(6):1330–1340. doi:10.1161/01.STR.0000165928.19135.3515879342
   PubMed Web of Science ®Google Scholar
• van de Weg FB, Kuik DJ, Lankhorst GJ. Post-stroke depression and functional outcome: a cohort study investigating the influence of depression on functional recovery from stroke. Clin Rehabil. 1999;13(3):268–272. doi:10.1191/02692159967249502210392654
   PubMed Web of Science ®Google Scholar
• King RB. Quality of life after stroke. Stroke. 1996;27(9):1467–1472.8784114
   PubMed Web of Science ®Google Scholar
• Schmid AA, Kroenke K, Hendrie HC, Bakas T, Sutherland JM, Williams LS. Poststroke depression and treatment effects on functional outcomes. Neurology. 2011;76(11):1000–1005. doi:10.1212/WNL.0b013e318210435e21403112
   PubMed Web of Science ®Google Scholar
• Bozikas VP, Gold G, Kövari E, et al. Pathological correlates of poststroke depression in elderly patients. Am J Geriatr Psychiatry. 2005;13(2):166–169. doi:10.1176/appi.ajgp.13.2.16615703326
   PubMed Web of Science ®Google Scholar
• Gaete JM, Bogousslavsky J. Post-stroke depression. Expert Rev Neurother. 2008;8(1):75–92. doi:10.1586/14737175.8.1.7518088202
   PubMedGoogle Scholar
• Murakami T, Hama S, Yamashita H, et al. Neuroanatomic pathways associated with poststroke affective and apathetic depression. Am J Geriatr Psychiatry. 2013;21(9):840–847. doi:10.1016/j.jagp.2013.01.05723567364
   PubMed Web of Science ®Google Scholar
• Brodaty H, Withall A, Altendorf A, Sachdev PS. Rates of depression at 3 and 15 months poststroke and their relationship with cognitive decline: the Sydney Stroke Study. Am J Geriatr Psychiatry. 2007;15(6):477–486. doi:10.1097/JGP.0b013e3180590bca17545448
   PubMed Web of Science ®Google Scholar
• Tenev VT, Robinson RG, Jorge RE. Is family history of depression a risk factor for poststroke depression? Meta-analysis. Am J Geriatr Psychiatry. 2009;17(4):276–280. doi:10.1097/JGP.0b013e3181953b6e19307856
   PubMed Web of Science ®Google Scholar
• Loubinoux I, Kronenberg G, Endres M, et al. Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med. 2012;16(9):1961–1969. doi:10.1111/j.1582-4934.2012.01555.x22348642
   PubMed Web of Science ®Google Scholar
• Berg A, Lönnqvist J, Palomäki H, Kaste M. Assessment of depression after stroke: a comparison of different screening instruments. Stroke. 2009;40(2):523–529. doi:10.1161/STROKEAHA.108.52770519074478
   PubMed Web of Science ®Google Scholar
• Spalletta G, Ripa A, Caltagirone C. Symptom profile of DSM-IV major and minor depressive disorders in first-ever stroke patients. Am J Geriatr Psychiatry. 2005;13(2):108–115. doi:10.1176/appi.ajgp.13.2.10815703319
   PubMed Web of Science ®Google Scholar
• Schubert DS, Burns R, Paras W, Sioson E. Increase of medical hospital length of stay by depression in stroke and amputation patients: a pilot study. Psychother Psychosom. 1992;57(1–2):61–66. doi:10.1159/0002885751584900
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature. 2008;455(7216):1054–1056. doi:10.1038/4551054a18948945
   PubMed Web of Science ®Google Scholar
• Quinones MP, Kaddurah-Daouk R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis. 2009;35(2):165–176. doi:10.1016/j.nbd.2009.02.01919303440
   PubMed Web of Science ®Google Scholar
• Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 2002;8(12):1439–1444. doi:10.1038/nm80212447357
   PubMed Web of Science ®Google Scholar
• Jung JY, Lee HS, Kang DG, et al. 1H-NMR-based metabolomics study of cerebral infarction. Stroke. 2011;42(5):1282–1288. doi:10.1161/STROKEAHA.110.59878921474802
   PubMed Web of Science ®Google Scholar
• Sussulini A, Prando A, Maretto DA, et al. Metabolic profiling of human blood serum from treated patients with bipolar disorder employing 1H NMR spectroscopy and chemometrics. Anal Chem. 2009;81(23):9755–9763. doi:10.1021/ac901502j19863109
   PubMed Web of Science ®Google Scholar
• Yang J, Chen T, Sun L, et al. Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013;18(1):67–78. doi:10.1038/mp.2011.13122024767
   PubMed Web of Science ®Google Scholar
• Hampel H, Kötter HU, Möller HJ. Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets. Alzheimer Dis Assoc Disord. 1997;11(2):78–87.
   Web of Science ®Google Scholar
• Zheng P, Gao HC, Li Q, et al. Plasma metabonomics as a novel diagnostic approach for major depressive disorder. J Proteome Res. 2012;11(3):1741–1748. doi:10.1021/pr201008222239730
   PubMed Web of Science ®Google Scholar
• Zheng P, Wang Y, Chen L, et al. Identification and validation of urinary metabolite biomarkers for major depressive disorder. Mol Cell Proteomics. 2013;12(1):207–214. doi:10.1074/mcp.M112.02181623111923
   PubMed Web of Science ®Google Scholar
• Zheng P, Chen JJ, Huang T, et al. A novel urinary metabolite signature for diagnosing major depressive disorder. J Proteome Res. 2013;12(12):5904–5911. doi:10.1021/pr400939q24224655
   PubMed Web of Science ®Google Scholar
• Fang J, Yan W, Jiang GX, Li W, Cheng Q. Serotonin transporter gene polymorphism in Chinese patients with poststroke depression: a case-control study. Stroke. 2011;42(5):1461–1463. doi:10.1161/STROKEAHA.110.59867221441157
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem. 1995;67(5):793–811.7762816
   PubMed Web of Science ®Google Scholar
• Sui W, Li L, Che W, et al. A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy. Clinics (Sao Paulo). 2012;67(4):363–373.22522762
   PubMed Web of Science ®Google Scholar
• Trygg J, Wold S. Orthogonal projections to latent structures (O-PLS). J Chemom. 2002;16(3):119–128. doi:10.1002/cem.695
   Web of Science ®Google Scholar
• Zheng P, Wei YD, Yao GE, et al. Novel urinary biomarkers for diagnosing bipolar disorder. Metabolomics. 2013;9(4):800–808. doi:10.1007/s11306-013-0508-y
   Web of Science ®Google Scholar
• Cloarec O, Dumas ME, Trygg J, et al. Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. Anal Chem. 2005;77(2):517–526. doi:10.1021/ac048803i15649048
   PubMed Web of Science ®Google Scholar
• Mahadevan S, Shah SL, Marrie TJ, Slupsky CM. Analysis of metabolomic data using support vector machines. Anal Chem. 2008;80(19):7562–7570. doi:10.1021/ac800954c18767870
   PubMed Web of Science ®Google Scholar
• Oikonomopoulou K, Li L, Zheng Y, et al. Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel. Br J Cancer. 2008;99(7):1103–1113. doi:10.1038/sj.bjc.660463018766180
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Gaur V, Kumar A. Nitric oxide mechanism in the protective effect of naringin against post-stroke depression (PSD) in mice. Life Sci. 2010;86(25–26):928–935. doi:10.1016/j.lfs.2010.04.01120433854
   PubMed Web of Science ®Google Scholar
• Fernstrom JD, Fernstrom MH. Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr. 2007;137(6 Suppl 1):1539S–1547S; discussion 1548S. doi:10.1093/jn/137.3.798S17513421
   PubMed Web of Science ®Google Scholar
• Kronenberg G, Balkaya M, Prinz V, et al. Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression. Biol Psychiatry. 2012;72(4):273–281. doi:10.1016/j.biopsych.2012.02.02622464799
   PubMed Web of Science ®Google Scholar
• Wu HC, Shiau CY, Chen HM, Chiou TK. Antioxidant activities of carnosine, anserine, some free amino acids and their combination. J Food Drug Anal. 2003;11(11):148–153.
   Google Scholar
• Bellia F, Vecchio G, Cuzzocrea S, Calabrese V, Rizzarelli E. Neuroprotective features of carnosine in oxidative driven diseases. Mol Aspects Med. 2011;32(4–6):258–266. doi:10.1016/j.mam.2011.10.00922020110
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Puhl H, Dieber-Rotheneder M, Waeg G, Rabl H. Effect of antioxidants on oxidative modification of LDL. Ann Med. 1991;23(5):573–581.1756027
   PubMed Web of Science ®Google Scholar